COMPANY NAME	REVENUES 12 Months Ending Q3 2024	MARKET SHARE 12 Months Q3 2024	MARKET SHARE MRQ Q3 2024	MARKET SHARE A Quarter Before Q2 2024
Avenir Wellness Solutions Inc	3.06	5.73%	1.37 %	1.95 %
Aquestive Therapeutics Inc	50.27	94.27%	98.63%	98.05%

AVRW's Market share relative to its competitors, as of Q3 2024 within the Major Pharmaceutical Preparations Industry

As of Q3 2024

COMPANY NAME	MARKET SHARE 12 Months Ending Q3 2024	MARKET SHARE 12 Months Ending Q2 2024	MARKET SHARE MRQ Q3 2024	MARKET SHARE Q2 2024
Avenir Wellness Solutions Inc	5.73%	8.03%	1.37 %	1.95 %
Aquestive Therapeutics Inc	94.27%	91.97%	98.63%	98.05%

AVRW's Market share relative to its competitors, as of Q3 2024 within the Healthcare Sector

As of Q3 2024

COMPANY NAME	MARKET SHARE 12 Months Ending Q3 2024	MARKET SHARE 12 Months Ending Q2 2024	MARKET SHARE MRQ Q3 2024	MARKET SHARE Q2 2024
Avenir Wellness Solutions Inc	5.73%	8.03%	1.37 %	1.95 %
Aquestive Therapeutics Inc	94.27%	91.97%	98.63%	98.05%

Note: Market share is calculated based on total revenue. To get a more accurate picture of Avenir Wellness Solutions Inc's market divisions, geographic dispersion, segments, products, and services, visit Avenir Wellness Solutions Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.